- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Oncodesign Precision Medicine SA (ALOPM)
Track today's live Oncodesign Precision Medicine (ALOPM) share price, performance and key data on this page with our current Paris:ALOPM stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Oncodesign Precision Medicine share price on the Paris exchange. Use the dropdown to switch exchange for the ALOPM share price, head to our technical summary section, which provides analysis on Oncodesign Precision Medicine share price buy/sell indicators using real-time data (or discuss the Oncodesign Precision Medicine (ALOPM) stock price today with other investors in the Oncodesign Precision Medicine EPA share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current EPA:ALOPM share price (ISIN: FR001400CM63) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncodesign Precision Medicine SA Share Price Today?
The Oncodesign Precision Medicine share price today is 0.28.
What Is the Stock Symbol for Oncodesign Precision Medicine SA
The stock symbol (or 'ticker') for Oncodesign Precision Medicine SA is "ALOPM."
What Stock Exchange Does Oncodesign Precision Medicine SA Trade On?
Oncodesign Precision Medicine SA is listed and trades on the Paris stock exchange.
Is Oncodesign Precision Medicine SA a Good Stock to Buy?
Determining whether Oncodesign Precision Medicine (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current EPA:ALOPM share price (ISIN: FR001400CM63) to enhance your trading decisions with our free investment tools and resources.
What Is the Oncodesign Precision Medicine SA Share Price Today?
The Oncodesign Precision Medicine share price today is 0.28.
What Is the Stock Symbol for Oncodesign Precision Medicine SA
The stock symbol (or 'ticker') for Oncodesign Precision Medicine SA is "ALOPM."
What Stock Exchange Does Oncodesign Precision Medicine SA Trade On?
Oncodesign Precision Medicine SA is listed and trades on the Paris stock exchange.
Is Oncodesign Precision Medicine SA a Good Stock to Buy?
Determining whether Oncodesign Precision Medicine (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
0.28
-0.01(-1.78%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.28
0.28
52 wk Range
0.28
0.92
Unusual trading volume
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.280.28
52 wk Range
0.280.92
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ALOPM Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
03/06/2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare ALOPM to Peers and Sector
Metrics to compare | ALOPM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipALOPMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 1.0x | −2.8x | −0.4x | |
PEG Ratio | 0.01 | −0.04 | 0.00 | |
Price/Book | 0.9x | 0.5x | 2.6x | |
Price / LTM Sales | 2.9x | 11.4x | 3.1x | |
Upside (Analyst Target) | - | 127.0% | 47.0% | |
Fair Value Upside | Unlock | 8.8% | 5.6% | Unlock |
Oncodesign Precision Medicine Société anonyme, a biopharmaceutical company, engages in the precision medicine business. The company’s product pipeline consist of OPM-101, a RIPK2 inhibitor for the treatment of inflammatory bowel disease and immuno-oncology; OPM-102 to treat cancer; and OPM-201, a LRRK2 inhibitor for the treatment of Parkinson’s disease. It also focuses on the development of a radiotheranostic molecule portfolio for the diagnosis and the treatment of advanced digestive cancers, as well as on developing treatment for pancreatic and other cancers. Oncodesign Precision Medicine Société anonyme was founded in 1995 and is based in Dijon, France.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Oncodesign Precision Medicine (Paris: ALOPM) Share Price Today?
The Oncodesign Precision Medicine stock price today is 0.28 EUR.
What Stock Exchange Does Oncodesign Precision Medicine (ALOPM) Trade On?
Oncodesign Precision Medicine is listed and trades on the Paris Stock Exchange.
What Is the Ticker (Stock Symbol) for Oncodesign Precision Medicine?
The stock symbol (also called a 'ticker') for Oncodesign Precision Medicine is "ALOPM."
What Is the Current Oncodesign Precision Medicine Market Capitalisation?
As of today, Oncodesign Precision Medicine (Paris: ALOPM) market cap is 5.35M EUR.
What Is Oncodesign Precision Medicine's (ALOPM) Earnings Per Share (TTM)?
The Oncodesign Precision Medicine EPS is currently 0.30 (Trailing Twelve Months).
When Is the Next Oncodesign Precision Medicine Earnings Date?
Oncodesign Precision Medicine's next earnings report will be released on 22/09/2026.
Is ALOPM a Buy or Sell From a Technical Analyst Perspective?
Based on today's Oncodesign Precision Medicine moving averages and other technical indicators, the daily buy/sell signal for ALOPM stock is Strong Sell.
How Many Times Has Oncodesign Precision Medicine Stock Split?
Oncodesign Precision Medicine has split 0 times. (See the ALOPM stock split history page for full effective split date and price information.)
What is the current trading status of Oncodesign Precision Medicine (Paris: ALOPM)?
As of 28/08/2026, Oncodesign Precision Medicine (ALOPM) is trading at a share price of 0.28 EUR, with a previous close of 0.28 EUR. The stock has fluctuated within a day range of 0.28 EUR to 0.28 EUR, while its 52-week range spans from 0.28 EUR to 0.92 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.